bromodeoxyuridine has been researched along with tirapazamine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 8 (88.89) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akaboshi, M; Hori, H; Kinashi, Y; Masunaga, S; Ono, K; Shibata, T; Suzuki, M; Takagaki, M | 1 |
| Hori, H; Kasai, S; Kinashi, Y; Masunaga, SI; Nagasawa, H; Ono, K; Suzuki, M; Takagaki, M; Uto, Y | 1 |
| Hori, H; Kasai, S; Kinashi, Y; Masunaga, S; Nagasawa, H; Ono, K; Suzuki, M; Takagaki, M; Uto, Y | 1 |
| Hori, H; Kinashi, Y; Masunaga, SI; Murayama, C; Nagasawa, H; Nishimura, Y; Ono, K; Sadahiro, S; Suzuki, M; Takagaki, M; Tsuchiya, I; Uto, Y | 1 |
| Hori, H; Kinashi, Y; Kirihata, M; Kobayashi, T; Masunaga, SI; Nagasawa, H; Ono, K; Sakurai, Y; Takagaki, M; Uto, Y | 1 |
| Hori, H; Kinashi, Y; Masunaga, S; Nagasawa, H; Nagata, K; Ohnishi, K; Ohnishi, T; Ono, K; Suzuki, M; Takahashi, A; Uto, Y | 1 |
| Hori, H; Kinashi, Y; Masunaga, S; Nagasawa, H; Nagata, K; Ono, K; Suzuki, M; Uto, Y | 1 |
| Baker, JH; Huxham, LA; Kyle, AH; McNicol, KL; Minchinton, AI | 1 |
| Hori, H; Kinashi, Y; Maruhashi, A; Masunaga, S; Nagasawa, H; Nagata, K; Ono, K; Sakurai, Y; Suzuki, M; Uto, Y | 1 |
9 other study(ies) available for bromodeoxyuridine and tirapazamine
| Article | Year |
|---|---|
Effects of bioreductive agents, tirapazamine and mitomycin C, on quiescent cell populations in solid tumors, evaluated by micronucleus assay.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Cisplatin; Cobalt Radioisotopes; Cytochalasin B; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Gamma Rays; Mice; Mice, Inbred C3H; Micronuclei, Chromosome-Defective; Micronucleus Tests; Mitomycin; Mitotic Index; Tirapazamine; Triazines | 1997 |
Usefulness of tirapazamine as a combined agent in chemoradiation and thermo-chemoradiation therapy at mild temperatures: reference to the effect on intratumor quiescent cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Radiation; Doxorubicin; Hyperthermia, Induced; Mice; Mice, Inbred C3H; Micronucleus Tests; Mitomycin; Radiation-Sensitizing Agents; Tirapazamine; Triazines | 2000 |
Change in oxygenation status in intratumour total and quiescent cells following gamma-ray irradiation, tirapazamine administration, cisplatin injection and bleomycin treatment.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Bleomycin; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Hypoxia; Cisplatin; Cytochalasin B; Injections; Mice; Micronucleus Tests; Tirapazamine; Triazines; Tumor Cells, Cultured | 2000 |
Radiosensitization effect by combination with paclitaxel in vivo, including the effect on intratumor quiescent cells.
Topics: Animals; Apoptosis; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Survival; Humans; Mice; Mice, Inbred C3H; Micronucleus Tests; Neoplasms; Paclitaxel; Radiation Tolerance; Radiation-Sensitizing Agents; Radiobiology; Radiotherapy Dosage; Time Factors; Tirapazamine; Triazines | 2001 |
Evaluation of the potential of p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, referring to the effect on intratumor quiescent cells.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Boranes; Boron Neutron Capture Therapy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Combined Modality Therapy; Cytochalasin B; Drug Screening Assays, Antitumor; Fluorescent Antibody Technique, Indirect; Hindlimb; Hyperthermia, Induced; Injections, Intraperitoneal; Interphase; Lymphoma; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Micronucleus Tests; Molecular Structure; Neutrons; Phenylalanine; Radiation-Sensitizing Agents; Radiometry; Tirapazamine; Triazines | 2001 |
Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Hypoxia; Cisplatin; Combined Modality Therapy; DNA Damage; Gamma Rays; Genes, p53; Head and Neck Neoplasms; Humans; Hyperthermia, Induced; Mice; Mice, Inbred BALB C; Mice, Nude; Micronucleus Tests; Neoplasm Proteins; Paclitaxel; Radiation-Sensitizing Agents; Tirapazamine; Triazines; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2003 |
The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumour cell populations.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Carcinoma, Squamous Cell; Combined Modality Therapy; Cyclic N-Oxides; Female; Fluorescent Antibody Technique; Hyperthermia, Induced; Mice; Mice, Inbred C3H; Micronucleus Tests; Neoplasm Transplantation; Neoplasms; Quinoxalines; Tirapazamine; Triazines | 2005 |
Tirapazamine causes vascular dysfunction in HCT-116 tumour xenografts.
Topics: Animals; Antimetabolites; Antineoplastic Agents; Blood Vessels; Bromodeoxyuridine; Cell Hypoxia; Cell Proliferation; Coloring Agents; Female; HCT116 Cells; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Mice; Mice, Inbred NOD; Mice, SCID; Necrosis; Platelet Endothelial Cell Adhesion Molecule-1; Regional Blood Flow; Skin Neoplasms; Tirapazamine; Transplantation, Heterologous; Triazines | 2006 |
The usefulness of a continuous administration of tirapazamine combined with reduced dose-rate irradiation using {gamma}-rays or reactor thermal neutrons.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Survival; Fluorescent Antibody Technique; Gamma Rays; Hyperthermia, Induced; Infusions, Parenteral; Mice; Mice, Inbred C3H; Micronucleus Tests; Neoplasm Transplantation; Neutrons; Radiation-Sensitizing Agents; Radiotherapy Dosage; Skin Neoplasms; Tirapazamine; Treatment Outcome; Triazines | 2006 |